Feb. 2 at 3:06 PM
$CSDX Put this on your watchlist asap
Their CS Protect-Hydrogel currently under FDA review
Competitors:
SpaceOARâ„¢ Hydrogel System which was acquired by
$BSX Boston Scientific for
$500M
Barrigel® acquired by Telefex
$TFX for
$600M
And literally no other direct competitors in market
Another similar one but not a (hydrogel spacer) is BioProtect Balloon Implantâ„¢ System currently in the process of being acquired for
$200M as of Jan,26, 2026
This is a pretty big OTC play. High value/low competition niche(hydrogel spacers), which seen major buyouts in the past. In the range of
$500M-
$600M
Going to share more DD on this play..